Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion

May 5, 2022

Minneapolis/St. Paul Business Journal

Related news

In the news

April 13, 2022

BCBS Company Wins New Medicare Business

Health Payer Specialist

In the news

April 8, 2022

Oncology Innovation: Optimism & Obstacles

Pharmaceutical Commerce